Sign in

CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473324577
Phone
617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$389,304
in 3 filings

Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lin Shao-Lee −$305K Chief Executive Officer sold 2% of stake
  2. Ray Sumita −$52K Chief Legal Compliance Officer sold 2% of stake
  3. Meluzio Michael Vincent −$32K VP, Prin. Accounting Officer sold 2% of stake

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-25 PASSERI DANIEL R CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +100,000 100,000
2022-03-25 Millar Kerri-Ann CHIEF FINANCIAL OFFICER Grant or award · Stock Option (right to buy) +10,000 10,000
2022-02-09 Suri Anish PRESIDENT AND CSO Grant or award · Stock Option (right to buy) +82,000 82,000
2022-02-09 Sandercock Colin SVP, GENERAL COUNSEL Grant or award · Stock Option (right to buy) +60,000 60,000
2022-02-09 Millar Kerri-Ann CHIEF FINANCIAL OFFICER Grant or award · Stock Option (right to buy) +85,000 85,000
2022-01-03 Fletcher Aaron G.L. Director Grant or award · Stock Option (right to buy) +10,000 10,000
2022-01-03 Kiener Peter A Director Grant or award · Stock Option (right to buy) +10,000 10,000
2022-01-03 Morich Frank Director Grant or award · Stock Option (right to buy) +10,000 10,000
2022-01-03 HOWSON TAMAR D Director Grant or award · Stock Option (right to buy) +10,000 10,000
2022-01-03 DRISCOLL FREDERICK W Director Grant or award · Stock Option (right to buy) +10,000 10,000
2022-01-03 Gray Cameron Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-12-20 Pienta Kenneth Chief Medical Officer Grant or award · Stock Option (right to buy) +80,000 80,000
2021-12-15 NASSHORN PATRICIA Chief Business Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2021-11-16 Kiener Peter A Director Option exercise +1,361 $2.86 $4K 1,361
2021-11-16 Kiener Peter A Director Sale −1,361 $18.02 $25K 0
2021-11-16 Kiener Peter A Director Option exercise · Stock Option (right to buy) −1,361 105,744
2021-11-15 Kiener Peter A Director Option exercise +18,815 $2.86 $54K 18,815
2021-11-15 Kiener Peter A Director Sale −18,815 $17.92 $337K 0
2021-11-15 Kiener Peter A Director Option exercise · Stock Option (right to buy) −18,815 107,105
2021-11-15 Suri Anish President and CSO Option exercise +8,000 $8.26 $66K 102,038

Page 8 of 17 · 323 trades